Larimar Therapeutics, Inc.

LRMR

Pharmaceutical Preparations · SIC 2834 · CIK 0001374690

SHARE:X LINKEDIN EMAIL

Revenue FY2025

—

Net Income

$(166.0M)

EPS (Basic)

—

Net Margin

—

ROE

-212.2%

Total Equity

$78.0M

Shares Out

104M

Larimar Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2012–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Revenue & Net Income (10Y)

Margin Trends

Investor Ownership · 1 fund in our universe

FundPosition Value% of AUMQoQ ChgWeight

Deerfield Management Company

$108.6M

0.6%

—

Insider Transactions

Reading stored insider transactions…